Unknown

Dataset Information

Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials.


ABSTRACT:

Objective

To evaluate the relative risk of pulmonary disease among patients with psoriasis, psoriatic arthritis, and inflammatory bowel disease treated with methotrexate.

Data sources

PubMed, Cochrane central register of controlled trials, and Embase to 9 January 2014.

Study selection

Double blind randomised controlled trials of methotrexate versus placebo or active comparator agents in adults with psoriatic arthritis, psoriasis, or inflammatory bowel disease. Studies with fewer than 50 participants or of less than 12 weeks' duration were excluded.

Data synthesis

Two investigators independently searched both databases. All authors reviewed selected studies. We compared relative risk differences using the Mantel-Haenszel random effects method to assess total res

SUBMITTER: Conway R 

PROVIDER: S-EPMC4358852 | biostudies-literature | 2015 Mar

REPOSITORIES: biostudies-literature